Table 1.
Bacterial pathogens associated with complicated skin and soft tissue infections (Doern et al 1999; Jones et al 1999, 2003; Bowler et al 2001; Fung et al 2003; Rennie et al 2003; Jodrá et al 2006)
| Frequency of isolation | ||
|---|---|---|
| Organism | All infections (%)a | Hospital-acquired infections (%) |
| Gram-positive aerobes | 57–60 | 29–55 |
| Staphylococcus aureus (all) | 29–46 | 13–19 |
| Staphylococcus aureus (MR) | 3–15 | 8–12 |
| Coagulase-negative staphylococci | 3–5 | 6–13 |
| Streptococci | 7–20 | 3–4 |
| Enterococcus spp. | 3–8 | 5–14 |
| Gram-negative aerobes | 22–26 | 25–47 |
| Pseudomonas aeruginosa | 3–11 | 3–9 |
| Escherichia coli | 4–13 | 7–12 |
| Enterobacter spp. | 5–6 | 4–9 |
| Klebsiella pneumoniae | 3–4 | 4–6 |
| Proteus spp. | 4–6 | 2–4 |
| Acinetobacter spp. | ND | 3–4 |
| Serratia spp. | 2–3 | 1–4 |
| Anaerobes | 17–33 | ND |
| Bacteroides spp. | 5–13 | ND |
| Peptostreptococcus spp. | 4–8 | ND |
| Prevotella spp. | 3 | ND |
| Clostridium spp. | 1 | ND |
a
Note: Infections in patients requiring hospitalization for treatment.
Abbreviations: MR, methicillin-resistant; ND, no data reported.